82
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Cisplatin ototoxicity and role of antioxidant on its prevention

ORCID Icon & ORCID Icon

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xin Tian, Xiangling He, Anqi Yao, Yalan You, Fan Yang, Keke Chen, Chengguang Zhu, Minhui Zeng, Qin Shi, Wenfang Tang, Xuelong Fan & Xiaojun Tao. (2022) The properties of cholesterol-modified pullulan nanoparticles with different PEG coatings and their anti-hepatoblastoma cell effects. Materials Technology 37:12, pages 2276-2288.
Read now

Articles from other publishers (3)

Filippo Valente, Edi Simoni, Erica Gentilin, Alessandro Martini, Elisabetta Zanoletti, Gino Marioni, Piero Nicolai & Laura Astolfi. (2022) Liquid Crystalline Nanoparticles Conjugated with Dexamethasone Prevent Cisplatin Ototoxicity In Vitro. International Journal of Molecular Sciences 23:23, pages 14881.
Crossref
Mariarita Candito, Edi Simoni, Erica Gentilin, Alessandro Martini, Gino Marioni, Serena Danti & Laura Astolfi. (2022) Neuron Compatibility and Antioxidant Activity of Barium Titanate and Lithium Niobate Nanoparticles. International Journal of Molecular Sciences 23:3, pages 1761.
Crossref
Thomas Foster, Corina Ionescu, Daniel Walker, Melissa Jones, Susbin Wagle, Božica Kovacevic, Daniel Brown, Momir Mikov, Armin Mooranian & Hani Al-Salami. (2021) Chemotherapy-induced hearing loss: the applications of bio-nanotechnologies and bile acid-based delivery matrices. Therapeutic Delivery 12:10, pages 723-737.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.